Skip to main content
SpringerLink
Log in

Australia: Ready for business

  • Feature
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

A sound infrastructure for biotechnology creates opportunities for international investors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. president of the Australian Biotechnology Association and senior manager, Biotech Australia Pty Limited, PO Box 20, Roseville, Sydney, New South Wales, 2069, Australia

    Graeme C. Woodrow

  2. director of planning and coordination, CSL Limited., 45 Poplar Road, Parkville, Melbourne, Victoria, 3052, Australia

    Ian Nisbet

  3. director of business development, AGEN Biomedical Ltd., 11 Durbell Street, Acacia Ridge, Brisbane, Queensland, 4111, Australia

    Mary E. Corbett

Authors
  1. Graeme C. Woodrow
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ian Nisbet
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mary E. Corbett
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Woodrow, G., Nisbet, I. & Corbett, M. Australia: Ready for business. Nat Biotechnol 15, 731–732 (1997). https://doi.org/10.1038/nbt0897-731

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0897-731

  • Springer Nature America, Inc.

Search

Navigation